Page last updated: 2024-09-03

butamidine and pentamidine

butamidine has been researched along with pentamidine in 8 studies

Compound Research Comparison

Studies
(butamidine)
Trials
(butamidine)
Recent Studies (post-2010)
(butamidine)
Studies
(pentamidine)
Trials
(pentamidine)
Recent Studies (post-2010) (pentamidine)
9022,411136477

Protein Interaction Comparison

ProteinTaxonomybutamidine (IC50)pentamidine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)1.2
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)3.278
Protein tyrosine phosphatase type IVA 3Homo sapiens (human)0.3
Solute carrier family 22 member 3Homo sapiens (human)9.5
PlasminogenHomo sapiens (human)7.3333
Urokinase-type plasminogen activatorHomo sapiens (human)10
Trypsin-1Homo sapiens (human)10
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.214
Muscarinic acetylcholine receptor M2Homo sapiens (human)1.425
Muscarinic acetylcholine receptor M4Homo sapiens (human)1.58
Muscarinic acetylcholine receptor M5Homo sapiens (human)2.885
Alpha-2A adrenergic receptorHomo sapiens (human)1.375
Cytochrome P450 2D6Homo sapiens (human)10
Amine oxidase [flavin-containing] AHomo sapiens (human)0.793
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.214
5-hydroxytryptamine receptor 2AHomo sapiens (human)1.639
5-hydroxytryptamine receptor 2CHomo sapiens (human)3.278
D(3) dopamine receptorHomo sapiens (human)3.998
Sodium-dependent dopamine transporter Homo sapiens (human)3.159
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.72
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)10
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.72
Protein tyrosine phosphatase type IVA 2Homo sapiens (human)0.3
Multidrug and toxin extrusion protein 2Homo sapiens (human)2.7
Protein tyrosine phosphatase type IVA 1Homo sapiens (human)0.3
Multidrug and toxin extrusion protein 1Homo sapiens (human)1.7033

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cory, M; Fairley, TA; Tidwell, RR1
Queener, SF1
Karplus, M; So, SS1
He, M; Ivanov, I; Jassim, BA; Qian, K; Yan, C; Zhang, J; Zheng, YG1
Cory, M; Geratz, JD; Hall, JE; Jones, SK; Ohemeng, KA; Tidwell, RR1
Allen, MA; Geratz, JD; Hall, JE; Jones, SK; Morrison, SD; Ohemeng, KA; Reddy, VV; Tidwell, RR1
Chenu, JP; Georges, P; Lancelot, JC; Perrine, D; Robba, M; Saturnino, C1
Bailly, C; Donkor, IO; Gentle, D; Thornalley, M; Waring, MJ1

Reviews

1 review(s) available for butamidine and pentamidine

ArticleYear
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
    Journal of medicinal chemistry, 1995, Nov-24, Volume: 38, Issue:24

    Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship

1995

Other Studies

7 other study(ies) available for butamidine and pentamidine

ArticleYear
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
    Journal of medicinal chemistry, 1992, Feb-07, Volume: 35, Issue:3

    Topics: DNA; Models, Molecular; Pentamidine

1992
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.
    Journal of medicinal chemistry, 1997, Dec-19, Volume: 40, Issue:26

    Topics: Cholinesterase Inhibitors; Dopamine beta-Hydroxylase; Drug Design; Enzyme Inhibitors; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Molecular Conformation; Molecular Structure; Neural Networks, Computer; Phosphorylases; Receptors, Aryl Hydrocarbon; Static Electricity; Structure-Activity Relationship

1997
Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.
    MedChemComm, 2017, Feb-01, Volume: 8, Issue:2

    Topics:

2017
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:4

    Topics: Amidines; Animals; Anti-Infective Agents; Benzamidines; Chemical Phenomena; Chemistry; DNA; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thymidylate Synthase; Trypsin Inhibitors

1990
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1990
Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2

    Topics: Acanthamoeba; Amebicides; Animals; Benzamidines; Pentamidine; Structure-Activity Relationship

1995
Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
    Molecular pharmacology, 1994, Volume: 46, Issue:2

    Topics: Base Sequence; Binding Sites; DNA; Humans; Molecular Sequence Data; Pentamidine; Pneumocystis; Structure-Activity Relationship

1994